Bismuth quadruple therapy for 14 days is preferred regimen for treatment-naive patients when antibiotic susceptibility is unknown. William D. Chey, MD, from Michigan Medicine in Ann Arbor, and ...

-- Leading H. pylori infection companies, such as TenNor Therapeutics, Cinclus Pharma, RaQualia Pharma, HK-inno.N, Braintree (Sebela Pharmaceuticals), and others, are developing new H. pylori ...

Several Twitter users on Thursday, November 25, took to the micro-blogging site to narrate their experiences with bacteria Helicobacter pylori (H. Pylori). The users observed that H. Pylori seems to ...

USPTO issues new patent covering Talicia[1] as a method for eradicating H. pylori regardless of patient Body Mass Index (BMI)[2], supporting Talicia protection until May 2042 The patent is supported ...

Helicobacter pylori (H. pylori) bacteria are commonly present in the stomach lining. In some cases, they can cause peptic and duodenal ulcers. Natural treatments — such as honey, aloe vera, and ...

The American Journal of Managed Care® (AJMC®): What treatment options or regimens for Helicobacter pylori exist that are not reflected in the 2017 American College of Gastroenterology (ACG) guidelines ...

Helicobacter pylori (H. pylori) is a type of bacteria that infects the stomach and small bowel. It is often symptomless, but it can increase the risk of ulcers, gastritis, and cancer, all of which can ...

While conversations about cancer risk often center on genetics and lifestyle choices, emerging research highlights a more insidious threat lurking in millions of American stomachs. Helicobacter pylori ...

Add Yahoo as a preferred source to see more of our stories on Google. Grabbing meals on the go, running endless errands, staying up late to finish work or school projects — we all have days when we ...

The H. pylori infection market is evolving as treatment strategies shift toward optimized, targeted combination therapies, including triple- and quadruple-drug regimens, bismuth-based therapies, and ...

The H. pylori infection market is evolving as treatment strategies shift toward optimized, targeted combination therapies, including triple- and quadruple-drug regimens, bismuth-based therapies ...